Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Dialysis (ASCEND-D)

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 2964 participants.

Also called NCT02879305

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 2,964 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02879305
  • EudraCT 2016-000541-31
Other papers using this trial's data
  • Daprodustat for the Treatment of Anemia in Patients Undergoing Dialysis The New England journal of medicine, 2021-12-16 DOI, PubMed 34739194

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Czechia, Denmark, Estonia, France, Germany, Greece, Hungary, India, Italy, Malaysia, Mexico, Netherlands, New Zealand, Norway, Poland, Portugal, Romania, Russia, Singapore, South Africa, South Korea, Spain, Sweden, Taiwan, Türkiye, Ukraine, United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02879305. Randomized; no masking; primary purpose treatment. Start 2016-09-28 (actual); primary completion 2020-11-09 (actual). Results posted on 2021-12-03.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Dialysis (ASCEND-D)
Condition
Anaemia
Condition
Aspergillosis, Allergic Bronchopulmonary
Intervention (Drug)
Daprodustat
Intervention (Drug)
rhEPO
Intervention (Drug)
Placebo
Intervention (Drug)
Iron therapy
Lead sponsor
GlaxoSmithKline (class: industry)

Record details

Record id
cardio:ct-nct02879305
Content hash
fbd83bf7fe4266073b83dd92d8b9e8b7f7b931cb219674496f4693aadf4deaf1